American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (988)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (941)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1257)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (312)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (64)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5174)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5555)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Machine learning of genomic factors in 1,961 patients with acute myeloid leukemia identifies patients with very good or very poor prognosis who do not benefit from allogeneic hematopoietic cell transplant in first remission
    Meeting Abstract

    Fleming, S.; Tsai, C. H.; Dohner, H.; Dohner, K.; Papaemmanuil, E.; Tien, H. F.; Reynolds, J.; Wei, A. H.; Hou, H. A.
    Blood (2021)

    Fulltext@MSK | Save
  • Brentuximab vedotin as consolidation therapy following autologous stem cell transplantation in children and adolescents with relapsed/refractory Hodgkin lymphoma: A multi-center retrospective analysis
    Meeting Abstract

    Forlenza, C. J.; Rosenzweig, J.; Mauguen, A.; Buhtoiarov, I.; Cuglievan, B.; Dave, H.; Deyell, R. J.; Flerlage, J.; Franklin, A.; Krajewski, J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • A global phase 2 study of valemetostat tosylate (valemetostat) in patients with relapsed or refractory (R/R) peripheral T-cell lymphoma (PTCL), including R/R adult T-cell leukemia/lymphoma (ATL) - VALENTINE-PTCL01
    Meeting Abstract

    Foss, F. M.; Porcu, P.; Horwitz, S. M.; Izutsu, K.; Ishitsuka, K.; Kato, K.; Jin, J.; Du, Y.; Inoue, A.
    Blood (2021)

    Fulltext@MSK | Save
  • TP53 mutations and RNA binding protein MUSASHI 2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma
    Meeting Abstract

    Erazo, I. T.; Evans, C. M.; Zakheim, D.; Chu, K. L.; Barbash, O.; Refermat, A. Y.; Batlevi, C. L.; Younes, A.; Kharas, M. G.
    Blood (2021)

    Fulltext@MSK | Save
  • Clinical outcomes and CNS relapse risk in patients with primary cutaneous DLBCL, leg type treated in the rituximab era: Long-term follow-up of a single-center experience
    Meeting Abstract

    Falchi, L.; Qiu, A.; Ewalt, M. D.; Batlevi, C. L.; Caron, P. C.; Hamlin, P. A.; Hamilton, A.; Horwitz, S. M.; Joffe, E.; Khan, N.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • KIR-HLA interactions lack clinical utility in matched unrelated donor transplantation for AML: An analysis of the CIBMTR and DRST registries
    Meeting Abstract

    Fein, J. A.; Shouval, R.; Krieger, E.; Baldauf, H.; Fleischhauer, K.; Kroeger, N.; Horowitz, M. M.; Maiers, M.; Malmberg, K. J.; Miller, J. S.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • DNMT3A mutations in the hematopoietic system promote colitis-associated colon cancer: A model of clonal hematopoiesis in solid tumors
    Meeting Abstract

    Feng, Y.; Newsome, R.; Robinson, T.; Bowman, R. L.; Zuniga, A.; Hall, K.; Bernsten, C.; Shabashvili, D.; Krajcik, K.; Gunaratne, C.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Effect of brentuximab vedotin addition to chemotherapy and prognostic factors in patients with relapsed/refractory hodgkin lymphoma: A large multi-trial analysis based on individual patient data
    Meeting Abstract

    Driessen, J.; de Wit, F.; Herrera, A. F.; Zinzani, P. L. L.; LaCasce, A. S.; Moskowitz, C. H.; Garcia-Sanz, R.; Cole, P. D.; Fuchs, M.; Mueller, H.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Entospletinib (ENTO) and decitabine (DEC) combination therapy in older newly diagnosed (ND) acute myeloid leukemia (AML) patients with mutant TP53 or complex karyotype is associated with poor response and survival: A phase 2 sub-study of the Beat AML Master Trial
    Meeting Abstract

    Duong, V. H.; Ruppert, A. S.; Mims, A. S.; Borate, U.; Stein, E. M.; Baer, M. R.; Stock, W.; Kovacsovics, T.; Blum, W. G.; Arellano, M. L.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Deep phenotyping reveals expansion of T follicular regulatory cells and triple positive (CTLA4, TIGIT, PD1) exhausted effector memory T cells characterizing the immunosuppressive microenvironment in follicular lymphoma
    Meeting Abstract

    El Daker, S.; Freeman, D.; Baik, J.; Zhu, M.; Chattopadhyay, P.; Roshal, M.; Dogan, A.; Galera, P.
    Blood (2021)

    Fulltext@MSK | Save